| Sep 3 |
QIAGEN N.V. announces conversion price of new net share settled convertible bonds
|
| Sep 3 |
QIAGEN N.V. announces successful placement of new net share settled convertible bonds
|
| Sep 3 |
QIAGEN N.V. launches non-US offering of net share settled convertible bonds
|
| Aug 30 |
Why Is Qiagen (QGEN) Down 0.3% Since Last Earnings Report?
|
| Aug 30 |
QIAGEN and AstraZeneca Expand Pact to Develop CDx in Chronic Diseases
|
| Aug 29 |
Qiagen, AstraZeneca expand companion diagnostic pact beyond cancer
|
| Aug 28 |
QIAGEN expands QIAstat-Dx into precision medicine through partnership for companion diagnostics in chronic diseases
|
| Aug 27 |
Reasons to Retain QIAGEN Stock in Your Portfolio Now
|
| Aug 22 |
Why Qiagen (QGEN) is a Top Momentum Stock for the Long-Term
|
| Aug 6 |
Myriad Genetics Reports Strong Second Quarter 2024 Financial Results, including 15% Revenue Growth Year-Over-Year; Raises 2024 Financial Guidance and Long-Term Revenue Growth Target to 12%
|
